SYDNEY FREEDMAN: Open Payments
NPI 1730884123 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 17 payments from 9 companies in 2025. Trend: 2023 $721 · 2024 $1,549 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Janssen Scientific Affairs, LLC | 1 | $65 |
| LEO Pharma Inc. | 2 | $49 |
| Amgen Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Botanix SB Inc | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $17 |
| Organon LLC | 2 | $12 |
Products named: TREMFYA, SKYRIZI, ADBRY, COSENTYX, OTEZLA, DUPIXENT, SOFDRA, NEMLUVIO.
Industry payments across IL — which companies pay providers there.
